|Day Low/High||11.15 / 11.20|
|52 Wk Low/High||8.55 / 11.43|
Several stocks trading near $5 were moving on above-average volume during Friday's session.
Several stocks trading near $5 were moving on above-average volume during Thursday's session.
Several stocks trading near $5 were poised to move on above-average volume during Monday's session.
Guests include Michael Corbett, fund manager for the Corbett Micro Cap Opportunities fund, Marilyn Cohen, author of "Bonds Now!" and TheStreet.com's Stocks Under $10 portfolio manager David Peltier.
Several stocks trading near $5 were poised to move on above-average volume during Tuesday's session.
Several stocks trading under $5 were poised to move on above-average volume during Monday's session.
SciClone Pharmaceuticals was trading sharply lower on a jump in volume after the company said it ended a clinical trial of a late-stage pancreatic cancer drug.
SciClone Pharma shares dive after company halts trial of RP101 for pancreatic cancer
SciClone Pharma says it stopped study of cancer drug on recommendation from reviewers
Guests include Marc Lichtenfeld, senior analyst at Mt. Vernon Research, The Street.com's biotech reporter Adam Feuerstein, Breakout Stocks editor Bryan Ashenberg and Patrick Galley, portfolio manager for the RiverNorth Core Opportunity fund.
Friedhelm Blobel, the company's president and CEO, will take on the COO duties.
SciClone Pharmaceuticals jumps after its melanoma treatment gets orphan-drug status.
SciClone Pharmaceuticals surges after posting a narrower-than-expected loss.
SciClone Pharmaceuticals tumbles 41% after its hepatitis C drug fails in a late-stage trial.
Some observers call the biotech's accounts-receivable trend 'a concern.'
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.